16. The outcome of obstructive sleep apnea treatment in children with tonsillar hypertrophy by leukotriene receptor antagoinists
Main Article Content
Abstract
The study evaluates the effectiveness of mild and moderate obstructive sleep apnea syndrome treatment in children with adenoid and tonsillar hypertrophy by leukotriene receptor antagoinists. A total of 63 children from 2 - 12 years old with tonsillar hypertrophy diagnosed with OSAS at the National Children's Hospital between August 2016 and December 2019 were included. The standard for diagnosis of OSAS in children is the apnea-hypopnea index (AHI) ≥ 1 measured by polysomnography during sleep, condition is considered as mild with AHI level between 1 to 5 (1 ≤ AHI < 5) and moderate as AHI level between 5 to 10 (5 ≤ AHI < 10). Results: After 3 months of treatment, there were improvements in the indicators on the sleep respiratory polygraph and all clinical symptom groups. Nearly 50% of children no longer have apnea according to AHI criteria < 1. Treatment with leukotriene receptor antagoinists improves both clinical symptoms and respiratory polygraphs, which can be used as an alternative to surgery.
Article Details
Keywords
Obstructive sleep apnea syndrome, adenotonsillectomy, Respiratory polygraphy, leukotriene receptor antagoinists
References
2. Rapid Response Report: Summary with Critical Appraisal. Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines. Canadian Agency for Drugs and Technologies in Health; 2014. Accessed April 23, 2023. http://www.ncbi.nlm.nih.gov/books/NBK195647/
3. Lumeng JC, Chervin RD. Epidemiology of Pediatric Obstructive Sleep Apnea. Proc Am Thorac Soc. 2008;5(2):242-252. doi:10.1513/pats.200708-135MG
4. Guilleminault C, Huang Y shu, Glamann C, et al. Adenotonsillectomy and obstructive sleep apnea in children: a prospective survey. Otolaryngol--Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. 2007;136(2):169-175. doi:10.1016/j.otohns.2006.09.021
5. Bhattacharjee R, Kim J, Kheirandish-Gozal L, et al. Obesity and obstructive sleep apnea syndrome in children: a tale of inflammatory cascades. Pediatr Pulmonol. 2011;46(4):313-323. doi:10.1002/ppul.21370
6. Brietzke SE, Gallagher D. The effectiveness of tonsillectomy and adenoidectomy in the treatment of pediatric obstructive sleep apnea/hypopnea syndrome: a meta-analysis. Otolaryngol--Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. 2006;134(6):979-984. doi:10.1016/j.otohns.2006.02.033
7. Friedman M, Wilson M, Lin HC, et al. Updated systematic review of tonsillectomy and adenoidectomy for treatment of pediatric obstructive sleep apnea/hypopnea syndrome. Otolaryngol-Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. 2009;140(6):800-808. doi:10.1016/j.otohns.2009.01.043
8. Tsaoussoglou M, Lianou L, Maragozidis P, et al. Cysteinyl leukotriene receptors in tonsillar B- and T-lymphocytes from children with obstructive sleep apnea. Sleep Med. 2012;13(7):879-885. doi:10.1016/j.sleep.2012.03.010
9. Shen Y, Xu Z, Huang Z, et al. Increased cysteinyl leukotriene concentration and receptor expression in tonsillar tissues of Chinese children with sleep-disordered breathing. Int Immunopharmacol. 2012;13(4):371-376. doi:10.1016/j.intimp.2012.05.009
10. Rodrigues MM, Dibbern RS, Goulart CWK. Correlation between subjective classification of snoring and the apnea-hypopnea index. Sleep Sci. 2010;3:103-106.
11. Maimon N, Hanly PJ. Does snoring intensity correlate with the severity of obstructive sleep apnea? J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2010;6(5):475-478.
12. Chervin RD, Hedger K, Dillon JE,et al. Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med. 2000;1(1):21-32. doi:10.1016/s1389-9457(99)00009-x
13. Chervin RD, Weatherly RA, Garetz SL, et al. Pediatric sleep questionnaire: prediction of sleep apnea and outcomes. Arch Otolaryngol Head Neck Surg. 2007;133(3):216-222. doi:10.1001/archotol.133.3.216
14. Tamana SK, Smithson L, Lau A, et al. Parent-Reported Symptoms of Sleep-Disordered Breathing Are Associated With Increased Behavioral Problems at 2 Years of Age: The Canadian Healthy Infant Longitudinal Development Birth Cohort Study. Sleep. 2017;41(1):zsx177. doi:10.1093/sleep/zsx177
15. Goldbart AD, Greenberg-Dotan S, Tal A. Montelukast for children with obstructive sleep apnea: a double-blind, placebo-controlled study. Pediatrics. 2012;130(3):e575-580. doi:10.1542/peds.2012-0310
16. Kheirandish-Gozal L, McManus CJT, Kellermann GH, et al. Urinary neurotransmitters are selectively altered in children with obstructive sleep apnea and predict cognitive morbidity. Chest. 2013;143(6):1576-1583. doi:10.1378/chest.12-2606
17. Dayyat E, Serpero LD, Kheirandish-Gozal L, et al. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest. 2009;135(5):1142-1149. doi:10.1378/chest.08-2102
18. Goldbart AD, Goldman JL, Veling MC, et al. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med. 2005;172(3):364-370. doi:10.1164/rccm.200408-1064OC
19. Bluher AE, Brawley CC, Cunningham TD,et al. Impact of montelukast and fluticasone on quality of life in mild pediatric sleep apnea. Int J Pediatr Otorhinolaryngol. 2019;125:66-70. doi:10.1016/j.ijporl.2019.06.027